Human Papillomavirus Infections
📧 Sign up to get email alerts when something new happens for Human Papillomavirus Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Impact Of Intralesional Tuberculin Ppd Injection On Anogenital [Phase 2]
Phase 2 clinical trial evaluating intralesional tuberculin PPD injection for anogenital human papillomavirus infections has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-28Clinical Trial Update: ICI-VPH: Impact of HPV Immunisation Schedules Against HPV [Phase 3]
Phase 3 trial update on the impact of HPV vaccination schedules on outcomes related to Human Papillomavirus infections.
-
CLINICAL_TRIALS trial_result · 2021-11-09Clinical Trial Update: Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix [Phase 1, Phase 2]
Phase 1/2 study evaluating safety, reactogenicity and immunogenicity of Ad26- and MVA-vectored vaccine components for HPV16/HPV18 cervical i…
-
CLINICAL_TRIALS withdrawal · 2020-11-10Clinical Trial Update: Inflammation and Co-Infections in D²EFT [Phase 4]
A Phase 4 trial examining inflammation and co-infections in HIV/AIDS with multiple herpesvirus-related infections has been withdrawn.
-
CLINICAL_TRIALS research · 2015-12-10Clinical Trial Update: GARDASIL™ Vaccine Impact in Population Study (V501-033)
Clinical trial update on GARDASIL vaccine impact in a population study (NCT01077856) completed with results posted in 2015.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-05-04Clinical Trial Update: A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018) [Phase 3]
Phase 3 trial update for Gardasil (V501) in preadolescents and adolescents completed with results posted in 2010.